Dr Janet Graham

Dr Janet Graham is a distinguished Consultant Medical Oncologist who specialises in the comprehensive management and non-surgical treatment of gastrointestinal cancers. Dedicated to delivering compassionate, evidence-based care, Dr Graham focuses on designing personalised treatment plans that address each patient's individual diagnosis and health needs. She collaborates closely with wider multidisciplinary medical teams to provide holistic and reassuring support throughout every stage of care.

Her clinical practice encompasses a broad range of digestive tract malignancies, including colorectal, pancreatic, hepatobiliary, and upper gastrointestinal cancers. Dr Graham possesses particular clinical interest in advanced biomarker testing, including RAS, BRAF, and microsatellite instability (MSI) analysis, which allows for highly targeted therapeutic interventions. Her approach integrates standard systemic treatments with modern precision medicine, giving patients access to state-of-the-art diagnostic and therapeutic strategies.

Dr Graham obtained her primary medical qualification (MBChB) before undertaking postgraduate research to earn a Doctor of Philosophy (PhD) in Oncology. She maintains a strong commitment to academic medicine, holding an Honorary Professor position and serving as a Lead Trainer for medical oncology specialists. Additionally, Dr Graham contributes her expertise to regional and national healthcare initiatives and serves on the medical advisory board for Bowel Cancer UK.

Recognised for her leadership in clinical research, Dr Graham serves as a Chief Investigator and Principal Investigator on numerous clinical trials spanning early-phase to late-phase studies. Her active involvement in research helps broaden access to innovative therapies, including novel immunotherapies and targeted biological agents. Through her combination of clinical expertise, active research, and empathetic communication, Dr Graham strives to deliver optimal patient outcomes and reassure individuals navigating complex cancer treatment.